环球墨非AI GMM 深 沪
等待开盘 09-18 09:30:00 美东时间
1.96
-0.020
-1.01%
华盛通- 最 高2.09
- 今 开1.95
- 成交量 8.32万股
- 最 低 1.95
- 昨 收 1.98
- 总市值 5727.06万
- 52周最高 11.55
- 市盈率 静 0.31
- 换手率 0.28%
- 52周最低 1.69
- 委 比 -19.84%
- 总股本 2921.97万
- 历史最高 232.05
- 量 比 0.03
- 振 幅 7.07%
- 历史最低 1.69
- 每 手 1
- 风险率 2.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Global Mofy and Beijing’s Shunyi District Government Hold In-Depth Talks on Comprehensive Cooperation
global mofy ai limited与北京市顺义区政府代表团于9月11日进行了深入交流，探讨了该公司在虚拟内容生产及3d数字资产开发方面的发展方向及合作机会，双方合作正在稳步推进。
09-15 12:30
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Oxford Industries, Inc. (NYSE:OXM) rose sharply in pre-market trading...
09-11 21:01
Global Mofy AI Launches New Website Domain to Strengthen Global AI Brand Identity
BEIJING, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited today announced the launch of its new corporate website, www.globalmofy.ai, as part of its global expansion strategy and commitment to integrating AI across its operations. The new domain replaces www.globalmofy.cn and reflects the company's technology-first brand identity. The updated website offers improved navigation, insights into its "Mofy Lab" technology, and access to its A...
09-11 12:00
Global Mofy Metaverse H1 EPS $0.87 Down From $5.40 YoY, Sales $26.729M Up From $19.919M YoY
Global Mofy Metaverse (NASDAQ:GMM) reported quarterly earnings of $0.87 per share. This is a 83.89 percent decrease over earnings of $5.40 per share from the same period last year. The company reported $26.729 million
08-18 21:10
Sanofi's Sarclisa Gains EU Approval For Transplant-Eligible Newly Diagnosed Multiple Myeloma Following GMMG-HD7 Phase 3 Results
Sanofi's Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myelomaApproval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment
07-25 13:17
Sanofi's Sarclisa Set To Expand Front-Line Multiple Myeloma Use In EU Following Positive CHMP Opinion Backed By MRD And PFS Gains
Recommendation based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity benefit and prolonged PFS compared to VRd aloneIf approved, it would represent
06-23 14:49
Global Mofy Completes Strategic Investment In Wetruck AI To Accelerate Industrial Application Of AI In High-Growth, Under-Digitized Sectors
Global Mofy AI Limited (the "Company" or "Global Mofy") (NASDAQ:GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the
06-09 20:33
Global Mofy Invests in Ethiopian Digital Freight Platform Wetruck AI to Advance Global AI Strategy and Drive Logistics Innovation in Africa
Global Mofy AI Limited has made a strategic investment in Wetruck AI, a digital freight platform based in Ethiopia, marking its first entry into Africa. The investment aims to leverage AI to enhance logistics efficiency and transparency in East Africa's growing digital infrastructure sector. Global Mofy will contribute its AI expertise to Wetruck AI's development, supporting its scalability and operational efficiency. Wetruck AI, founded by an in...
06-09 12:30
环球墨非上涨4.38%，报4.29美元/股，总市值7516.61万美元
3月20日，环球墨非(GMM)盘中上涨4.38%，截至23:33，报4.29美元/股，成交1.96万美元，总市值7516.61万美元。 财务数据显示，截至20...
03-20 23:33
环球墨非盘中异动 快速拉升5.95%
北京时间2025年01月24日03时34分，环球墨非（GMM.us）股票出现异动，股价快速上涨5.95%。截至发稿，该股报3.72美元/股，成交量2.9436万...
01-24 03:34
